Thiazolidinediones: an update. (Q54055332)

24 May 2018

title

Thiazolidinediones: an update. (English)

1 reference

24 May 2018

2

J Auwerx

1 reference

24 May 2018

K Schoonjans

1

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 March 2000

1 reference

24 May 2018

published in

The Lancet

1 reference

24 May 2018

volume

355

1 reference

24 May 2018

issue

9208

1 reference

24 May 2018

page(s)

1008-1010

1 reference

24 May 2018

PPARgamma, the ultimate thrifty gene

cites work

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

Medical significance of peroxisome proliferator-activated receptors.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

Adipogenesis and obesity: rounding out the big picture

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

Transcriptional control of adipogenesis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

Obesity associated with a mutation in a genetic regulator of adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

PPAR gamma is required for placental, cardiac, and adipose tissue development

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

Life without white fat: a transgenic mouse

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

Troglitazone: a review of its use in the management of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

1 reference

7 January 2021

Hepatic Dysfunction Associated with Troglitazone

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

An autopsy case of troglitazone-induced fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

Rosiglitazone and hepatic failure.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

Hepatocellular injury in a patient receiving rosiglitazone. A case report

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/ mice

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

BM 17.0744: a structurally new antidiabetic compound with insulin-sensitizing and lipid-lowering activity

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS1-4.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

Gene expression profile of aging and its retardation by caloric restriction

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(00)95002-3

7 January 2021

10.1016/S0140-6736(00)95002-3

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018